Bharat Immunologicals Complete Financial Statements
BIBCL • Review detailed financials to uncover trends, confirm thesis & journal trades
9 Years of Data
2023 - 2015
Complete Financial Data Export
Export complete financial statements for Bharat Immunologicals (BIBCL).
Downloads include all available records across all periods.
For market performance, see the
BIBCL stock price today
.
Profitability Ratios
Net Profit Margin
-36.17%
2023 data
EBITDA Margin
-34.04%
2023 data
Operating Margin
-41.00%
2023 data
Return on Assets
-9.14%
2023 data
Return on Equity
-19.32%
2023 data
Balance Sheet Ratios
Current Ratio
5.50
2023 data
Debt to Equity
2.11
2023 data
Equity Ratio
47.31%
2023 data
Asset Turnover
0.25
2023 data
Year-over-Year Growth Analysis
Comparing March 2023 vs Period
Revenue Growth
-80.9%
Year-over-Year
Net Profit Growth
-5.9%
Year-over-Year
EBITDA Growth
-6.3%
Year-over-Year
Expense Growth
-60.3%
Year-over-Year
Assets Growth
-12.7%
Year-over-Year
Equity Growth
-16.2%
Year-over-Year
Liabilities Growth
-12.7%
Year-over-Year
Operating Cash Flow Growth
+126.2%
Year-over-Year
Financing Cash Flow Growth
-133.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 47 | 80 | 87 | 68 | 88 | 36 | 125 | 129 | 147 |
| Expenses | 25 | 63 | 83 | 106 | 77 | 93 | 43 | 112 | 133 | 143 |
| EBITDA | -17 | -16 | -4 | -19 | -9 | -5 | -7 | 14 | -4 | 4 |
| Operating Profit Margin % | -13.00% | -41.00% | -6.00% | -24.00% | -16.00% | -11.00% | -24.00% | 10.00% | -4.00% | 2.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 8 | 7 | 6 | 5 | 5 | 2 | 1 | 4 | 5 | 1 |
| Profit Before Tax | -25 | -23 | -10 | -24 | -14 | -7 | -8 | 9 | -9 | 2 |
| Tax | 0 | -6 | -1 | -6 | -4 | -2 | -4 | 3 | -3 | 1 |
| Net Profit | -18 | -17 | -9 | -18 | -10 | -6 | -4 | 7 | -6 | 2 |
| Earnings Per Share (₹) | -4.20 | -3.95 | -2.03 | 1.10 | -2.36 | -1.34 | -0.99 | 1.51 | -1.44 | 0.36 |
Related Pages for Bharat Immunologicals
Additional stock information and data for BIBCL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Total Assets | 186 | 213 | 104 | 127 | 125 | 53 | 59 | 68 | 80 |
| Current Assets | 33 | 65 | 34 | 93 | 99 | 38 | 47 | 60 | 74 |
| Fixed Assets | 115 | 116 | 4 | 5 | 5 | 5 | 5 | 6 | 6 |
| Capital Work in Progress | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 70 | 97 | 68 | 122 | 120 | 48 | 53 | 63 | 74 |
| LIABILITIES | |||||||||
| Total Liabilities | 186 | 213 | 104 | 127 | 125 | 53 | 59 | 68 | 80 |
| Current Liabilities | 6 | 6 | 6 | 6 | 6 | 3 | 3 | 3 | 4 |
| Non-Current Liabilities | |||||||||
| SHAREHOLDERS' EQUITY | |||||||||
| Total Equity | 88 | 105 | 34 | 21 | 31 | 38 | 42 | 35 | 41 |
| Share Capital | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 |
| Reserves & Surplus | 45 | 62 | -9 | -23 | -13 | -6 | -1 | -8 | -2 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 11 | -42 | 12 | 34 | -32 | 3 | -17 | -9 | 8 |
| Investing Activities | 1 | 1 | 1 | 1 | 1 | -1 | 1 | 1 | 0 |
| Financing Activities | -15 | 45 | -12 | -34 | 31 | -1 | -3 | -2 | -1 |
| Net Cash Flow | -3 | 3 | 0 | 1 | -1 | 1 | -20 | -10 | 7 |